Skip to main content

LACROIX : EBITDA margin at 7.6%, in line with the target. Net income impacted by significant non-cash depreciations, strongly positive Free Cash Flow (+€36.6m) and sharp reduction in net debt.

31/03/2026 EBITDA margin at 7.6%, in line with the targetNet income impacted by significant non-cash depreciations,strongly positive Free Cash Flow (+€36.6m) and sharp reduction in net debt Moderate revenue growth and maintained EBITDA margin expected in 2026Full confirmation of 2027 financial targets€m 2025   2024restated for North America   2024 non-restatedRevenue 445.5 494.4 635.5Recurring EBITDA 34.1 39.0 25.4as % of revenue 7.6% 7.9% 4.0%Recurring operating income 21.1 26.3 5.2as % of revenue 4.7% 5.3% 0.8%Opertaing income 17.0 19.7 (20.8)Financial result (3.3) (7.3) (12.5)Income tax (4.8) (4.5) (0.3)Net income from continuing operations 8.9 7.8 (33.5)Net income from discontinued operations* (56.0) (57.0) (15.7)Consolidated net income (47.1) (49.2) (49.2)Net income, Group share (39.7) (33.8) (33.8)*Discontinued...

Continue reading

Reading International Reports Fourth Quarter and Full Year 2025 Results

Earnings Call Webcast to Discuss 2025 Fourth Quarter and Full Year Financial Results Scheduled to Post to Corporate Website by Thursday, April 02, 2026 NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today reported its results for the fourth quarter and year ended December 31, 2025. Key Financial Results – Fourth Quarter 2025 compared to Fourth Quarter 2024Total Revenues were $50.3 million compared to $58.6 million in Q4 2024. Operating Loss was $1.0 million compared to Operating Income of $1.5 million in Q4 2024. Net Loss was $2.6 million compared to a Net Loss of $2.2 million in Q4 2024. Basic Loss per Share was $0.11 compared...

Continue reading

Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025

PLAINVIEW, N.Y., March 31, 2026 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months and year ended December 31, 2025. “The Company’s annual revenue reached a record $89.1 million for the fiscal year 2025, an increase of $2.3 million, or 3%, when compared to the prior year’s revenue, despite the sale of its healthcare IT business unit in November 2025,” commented Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation. “Gross profit for 2025 was $54.7 million, up by $2.6 million, or 5% year-over-year, and net income for 2025 increased to $1.6 million from $951 thousand in 2024, mainly due to the increase...

Continue reading

KELA Group Reports Over 100% YoY Growth Driven by Enterprise Demand for Consolidated, AI-Driven Active Cyber Defense

The group continues expanding into North America and across key global markets, driven by demand for its AI-powered Exposure Management Platform that unifies Cyber Threat Intelligence, External Attack Surface Management, and Third-Party Risk Tel Aviv, Israel, March 31, 2026 (GLOBE NEWSWIRE) — NEW YORK, NY and TEL AVIV, ISRAEL – March 31, 2026 – KELA Group, a global leader in Cyber Threat Intelligence and Exposure Management, today announced record growth for its previous fiscal year. As enterprises favor unified exposure management and proactive cyber defense strategies, KELA Group has seen accelerating market adoption, achieving a 101% year-over-year (YoY) growth in bookings and the highest number of 5-star reviews in its Gartner Peer Insights category. These achievements are further reflected in the acceleration of customer acquisition...

Continue reading

Kartoon Studios Provides Business Update

CEO AND CFO PROVIDE GROUNDBREAKING AI ANIMATED EARNINGS UPDATE IN INTERVIEW WITH A.A. MILNE’S WINNIE THE POOH, AND TENTPOLE CHARACTERSOVERALL REVENUE INCREASED YEAR-OVER-YEAR 21% IN 2025 TO $39.4 MILLION PRODUCTION SERVICES REVENUE INCREASED 50% YEAR-OVER-YEAR TO $26.8 MILLION KARTOON CHANNEL WATCH TIME SURGES 85% YEAR-OVER-YEAR, AMIDST RECORD SUBSCRIBERS AND BREAKOUT ENGAGEMENT ACROSS SVOD AND FAST PLATFORMS, AS GLOBAL DIGITAL DISTRIBUTION ECOSYSTEM SCALES KARTOON CHANNEL CONTINUES TO LEAD ALL COMPETITORS IN APPLE APP STORE VIEWER RATINGSOPERATING LOSS IMPROVES 24%; COMPANY TRANSITIONS TO HIGH-MARGIN FRANCHISE MONETIZATION IP-DRIVEN BUSINESS MODEL-NOT DEPENDENT ON ENERGY INPUT COSTS-POSITIONS COMPANY FOR RESILIENT, SCALABLE GROWTH IN A RISING COST ENVIRONMENT BEVERLY HILLS, Calif., March 31, 2026 (GLOBE NEWSWIRE) — Kartoon...

Continue reading

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

Encouraging Phase 2 HIT data and recent FDA feedback support continued advancement of CAD-1005 as Cadrenal’s near-term development priority; broader 12-LOX platform remains a longer-term opportunity PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) — Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, today reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update highlighting recent progress across its CAD-1005 program for HIT and broader 12-LOX inhibitor platform. The update reflects continued progress for CAD-1005, Cadrenal’s first-in-class 12-LOX inhibitor for suspected heparin-induced thrombocytopenia (HIT), including completion of its End-of-Phase...

Continue reading

Volatus Aerospace Reports Fiscal Year 2025 Financial Results

Revenue Growth of 26% year-over-year Defence Equipment revenues more than 2x from 2024 Total Assets of C$92M+, up ~60% year-over-year Europe & UK revenue grew 150%, driven by NATO-aligned defence business Current cash balance of ~C$41M Secured a NATO defence contract valued at up to C$9M in Dec 2025 Establishment of the Volatus Innovation & Drone Manufacturing Facility in Mirabel, QCMONTREAL, March 31, 2026 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSX: FLT) (OTCQX: TAKOF) (Frankfurt: ABB.F) (“Volatus” or the “Company”), a Canadian-controlled global aerospace and defence company delivering integrated uncrewed systems, aerial intelligence, and mission-critical operational services, today released its audited consolidated financial results for the fiscal year ended December 31, 2025. Fiscal 2025 was the Company’s first...

Continue reading

KOIL Energy Reports Fourth Quarter and Full Year 2025 Results

– Revenue of $7.3 million, 22% growth – Gross margin of 35% – Adjusted EBITDA margin of 10% HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) — KOIL Energy Solutions, Inc. (OTCQB: KLNG), a specialist in deepwater energy production and distribution equipment and services, released today its fourth quarter and full year 2025 results. “We achieved a record revenue of $7.3 million this quarter,” said Erik Wiik, President and Chief Executive Officer of KOIL Energy. “Our growth initiatives are delivering profitable growth with an EBITDA margin of 10% while we continue to invest heavily in growth.” Fourth Quarter 2025 Results: For the three months ending December 31, 2025, KOIL Energy generated revenues of $7.3 million dollars. This is 22% higher than Q4 last year and 14% higher than last quarter. Both...

Continue reading

BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET

HOLMDEL, N.J., March 31, 2026 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its fourth quarter (Q4’25) and year ended December 31, 2025 (2025) results. BIO-key will host an investor call today at 10:00am ET (details below). Highlights:  •   2025 Revenue:   $6.1M  •   2026 Outlook:   Solid revenue growth + improved bottom line  •   Preliminary Q1’26 Revenue:   $2.2M, up 37% vs. Q1’25 and 80% vs. Q4’25  •   2025 Cash Position:   $2.7M, up $2.3M vs. $0.4M vs. 2024BIO-key CEO, Mike DePasquale commented, “We had a broad base of achievements in 2025, the revenue and bottom-line benefits of which will be realized in early 2026 and beyond. In 2025, we completed our strategic transition to selling...

Continue reading

BlockchAIn Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Following Public Listing

Completed Business Combination and Began Trading on NYSE American Under Ticker Symbol “AIB” on March 17, 2026 Existing 40MW Operating Data Center Provides Revenue-Generating Base as Company Advances Growth Plan Over $500 Million in Potential Contract Value Pending Execution of Definitive Agreements Company to Host First Virtual Webinar in April 2026 to Discuss Financial Results and Growth Strategy NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) — BlockchAIn Digital Infrastructure, Inc. (NYSE American: AIB) (“BlockchAIn” or the “Company”), a developer and operator of digital infrastructure focused on artificial intelligence (“AI”) and high-performance computing (“HPC”) workloads, today reported financial results for the fiscal year ended December 31, 2025, and highlighted recent commercial and strategic developments. On March 16, 2026,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.